These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8264477)

  • 1. Fighting high cholesterol levels--lipid lowering drugs.
    Fidge NH
    Med J Aust; 1993 Dec 6-20; 159(11-12):815-9. PubMed ID: 8264477
    [No Abstract]   [Full Text] [Related]  

  • 2. New clinical perspectives of hypolipidemic drug therapy in severe hypercholesterolemia.
    Stefanutti C; Morozzi C; Di Giacomo S
    Curr Med Chem; 2012; 19(28):4861-8. PubMed ID: 22963620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-lowering drugs.
    Med Lett Drugs Ther; 2016 Oct; 58(1506):133-140. PubMed ID: 27755510
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholesterol and lipoprotein metabolism: Early Career Committee contribution.
    Zhang H; Temel RE; Martel C
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1791-4. PubMed ID: 25142876
    [No Abstract]   [Full Text] [Related]  

  • 5. Economics of lipid lowering with HMG CoA reductase inhibitors.
    Illingworth DR
    Clin Cardiol; 1995 Jun; 18(6):295, 363. PubMed ID: 7664501
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial.
    Jula A; Marniemi J; Huupponen R; Virtanen A; Rastas M; Rönnemaa T
    JAMA; 2002 Feb; 287(5):598-605. PubMed ID: 11829698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underutilization of lipid-lowering therapy in coronary artery disease.
    Batalla A; Hevia S; Reguero JR; Cubero GI
    Arch Intern Med; 2000 Sep; 160(17):2683-4. PubMed ID: 10999994
    [No Abstract]   [Full Text] [Related]  

  • 8. The CEPHEUS Pan-Asian survey: high low-density lipoprotein cholesterol goal attainment rate among hypercholesterolaemic patients undergoing lipid-lowering treatment in a Hong Kong regional centre.
    Chan RH; Chan PH; Chan KK; Lam SC; Hai JJ; Wong MK; Tam FC; Lam L; Chan CW; Lam YM; Siu DC; Tse HF; Lee SW
    Hong Kong Med J; 2012 Oct; 18(5):395-406. PubMed ID: 23018067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of coronary events: evidence from clinical trials.
    Gotto AM
    Curr Opin Lipidol; 1995 Dec; 6(6):345-7. PubMed ID: 8750245
    [No Abstract]   [Full Text] [Related]  

  • 10. Current perspectives on statins.
    Maron DJ; Fazio S; Linton MF
    Circulation; 2000 Jan; 101(2):207-13. PubMed ID: 10637210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of statins on triglyceride metabolism.
    Ginsberg HN
    Am J Cardiol; 1998 Feb; 81(4A):32B-35B. PubMed ID: 9526811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New lipid-lowering agents acting on LDL receptors.
    Scharnagl H; März W
    Curr Top Med Chem; 2005; 5(3):233-42. PubMed ID: 15857307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mode of action of lipid-lowering drugs.
    Fears R
    Baillieres Clin Endocrinol Metab; 1987 Aug; 1(3):727-54. PubMed ID: 2897841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Other therapies for reducing low-density lipoprotein cholesterol: medications in development.
    Stein EA
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):99-119. PubMed ID: 19217514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cerivastatin sodium, a new HMG-CoA reductase inhibitor, on biliary lipid metabolism in patients with hypercholesterolemia.
    Tazuma S; Yamashita G; Ochi H; Miura H; Kajihara T; Hattori Y; Miyake H; Nishioka T; Hyogo H; Sunami Y; Yasumiba S; Kajiyama G
    Clin Ther; 1998; 20(3):477-85. PubMed ID: 9663363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new reality: achieving cholesterol-lowering goals in clinical practice.
    Gaw A
    Atheroscler Suppl; 2002 Apr; 2(4):5-8; discussion 8-11. PubMed ID: 11976071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of lipid-lowering treatment in France--the CEPHEUS study.
    Ferrières J; Gousse ET; Fabry C; Hermans MP;
    Arch Cardiovasc Dis; 2008 Sep; 101(9):557-63. PubMed ID: 19041840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of high blood cholesterol in patients with coronary heart disease].
    Nagai Y; Yamashita S
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():675-81. PubMed ID: 12735049
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessing the clinical benefits of lipid-disorder drugs.
    Hiatt WR; Smith RJ
    N Engl J Med; 2014 Jan; 370(5):396-9. PubMed ID: 24476429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.